Adagio Medical Holdings, Inc. (ADGM) Financial Ratios
4 years of historical data (2021–2024) · Healthcare · Medical - Devices
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
0.73
-9% vs avg
5yr avg: 0.80
30Y Low0.8·High0.8
ROE
-270.0%
+0% vs avg
5yr avg: -270.0%
30Y Low-270%·High-270%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
ADGM Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Adagio Medical Holdings, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Market Cap | $15M | $16M | — | — | — |
| Enterprise Value | $10M | $12M | — | — | — |
| P/E Ratio → | -0.27 | — | — | — | — |
| P/S Ratio | 54.49 | 59.32 | — | — | — |
| P/B Ratio | 0.73 | 0.80 | — | — | — |
| P/FCF | — | — | — | — | — |
| P/OCF | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
ADGM EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| EV / Revenue | — | 43.26 | — | — | — |
| EV / EBITDA | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — |
| EV / FCF | — | — | — | — | — |
ADGM Profitability
Margins and return-on-capital ratios measuring operating efficiency
Adagio Medical Holdings, Inc. earns an operating margin of -23226.8%. Operating margins have compressed from -12652.4% to -23226.8% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -270.0% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Gross Margin | -620.1% | -620.1% | -335.3% | -363.0% | -328.9% |
| Operating Margin | -23226.8% | -23226.8% | -9314.0% | -12652.4% | -7646.3% |
| Net Profit Margin | -19986.2% | -19986.2% | -12715.3% | -12525.4% | -7384.4% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| ROE | -270.0% | -270.0% | — | — | — |
| ROA | -194.5% | -194.5% | -491.5% | -157.1% | -93.0% |
| ROIC | — | — | — | — | — |
| ROCE | -37413.2% | -37413.2% | — | -327.9% | -109.5% |
ADGM Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $21M exceeds total debt of $16M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Debt / Equity | 0.82 | 0.82 | — | — | — |
| Debt / EBITDA | — | — | — | — | — |
| Net Debt / Equity | — | -0.22 | — | — | — |
| Net Debt / EBITDA | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — |
| Interest Coverage | — | — | -16.84 | -174.55 | — |
Net cash position: cash ($21M) exceeds total debt ($16M)
ADGM Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Adagio Medical Holdings, Inc.'s current ratio of 3.27x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 2.93x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 0.52x to 3.27x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Current Ratio | 3.27 | 3.27 | 0.11 | 0.52 | 7.62 |
| Quick Ratio | 2.93 | 2.93 | 0.04 | 0.49 | 7.49 |
| Cash Ratio | 2.65 | 2.65 | 0.03 | 0.43 | 7.28 |
| Asset Turnover | — | 0.01 | 0.04 | 0.02 | 0.01 |
| Inventory Turnover | 0.75 | 0.75 | 0.39 | 2.38 | 3.47 |
| Days Sales Outstanding | — | 47.49 | 86.38 | — | 44.61 |
ADGM Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Adagio Medical Holdings, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — |
| FCF Yield | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $15M | $8M | $19M | $19M |
Peer Comparison
Compare ADGM with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 ADGMYou | $15M | -0.3 | — | — | -620.1% | -23226.8% | -270.0% | — | — |
 BEAT | $35M | -1.4 | — | — | — | — | -987.3% | — | — |
 CRMD | $621M | 3.9 | 3.8 | 3.6 | 88.5% | 48.2% | 66.6% | 49.7% | 0.9 |
 ATRC | $1B | -115.8 | 77.7 | 29.2 | 74.4% | -0.6% | -2.4% | -0.6% | 5.2 |
 ABLV | $33M | -3.7 | — | — | 9.2% | -6.8% | -80.2% | -81.3% | — |
 MEDP | $12B | 28.1 | 21.3 | 18.0 | 30.1% | 21.1% | 70.2% | 154.9% | 0.4 |
 BSX | $84B | 29.2 | 25.3 | 23.0 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
 ABT | $151B | 11.4 | 15.8 | 23.8 | 50.8% | 16.3% | 30.9% | 9.9% | 1.5 |
 IRTC | $4B | -89.8 | — | 118.8 | 70.6% | -4.9% | -36.6% | -5.2% | — |
 MDT | $100B | 21.6 | 14.3 | 19.3 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 SYK | $113B | 35.0 | 20.3 | 26.3 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
| Healthcare Median | — | 22.3 | 14.5 | 18.5 | 64.0% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 4 years · Updated daily
See ADGM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ADGM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ADGM vs BEAT
Side-by-side business, growth, and profitability comparison vs HeartBeam, Inc..
Start ComparisonADGM — Frequently Asked Questions
Quick answers to the most common questions about buying ADGM stock.
What is Adagio Medical Holdings, Inc.'s P/E ratio?
Adagio Medical Holdings, Inc.'s current P/E ratio is -0.3x. This places it at the 50th percentile of its historical range.
What is Adagio Medical Holdings, Inc.'s ROE?
Adagio Medical Holdings, Inc.'s return on equity (ROE) is -270.0%. The historical average is -270.0%.
Is ADGM stock overvalued?
Based on historical data, Adagio Medical Holdings, Inc. is trading at a P/E of -0.3x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Adagio Medical Holdings, Inc.'s profit margins?
Adagio Medical Holdings, Inc. has -620.1% gross margin and -23226.8% operating margin.